I concur. It was only a court ruling. With that avenue

New Post Public Reply Private Reply Replies (2) Message Board
jrockford
359
I concur. It was only a court ruling.

With that avenue exhausted, isn’t it time to just run the business? And by business I’m implying marketing the products which have been developed or in late stage development.

As a long term holder I have seen 400-700m slowly become 0. Don’t like it, but wasn’t counting on it. I am counting on the company delivering to its objectives; inc quickly signing a license agreement that should all but be wrapped up now and getting GenChoice approved. These should easily happen by EOY. Apparently been in the works for months.

I speak for myself (and I’ll assume on behalf of a few others) who aren't satisfied with the complete lack of results over the past 6-7 years. No excuses.

Friends and business don’t mix. Sad to say, I have long discounted your input. The J&J verdict cements it. Nothing personal, but trust needs to be earned its not unconditional. Your track record speaks volumes.

IMHO, the company should now be sold. If any of what you say is true, Platinum will deliver .25-$1.00/sh. So check the emotion and ego at the door and turn the company over to someone that can take it to the next level. Last I looked shareholders were concerned about return on investment.

Decision Diagnostics Corp (DECN) Stock Research Links

DECN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hyzon Motors Plans Delisting from Nasdaq—What This Means

Updated Category News Views 195

Hyzon Motors Announces Delisting from Nasdaq Hyzon Motors Inc. is making a significant shift regarding its stock trading status. This U.S. company, known for its commitment to high-performance hydrogen fuel cell technology, has decided to inform Nasdaq Stock Market of its intent to delist its Class A common stock and publicly traded warrants. This move comes as part of...

Continue Reading
Unlock the Potential of Crypto Staking with Keynode.net

Updated Category News Views 113

Your Gateway to High Returns in Crypto Staking As the digital currency landscape continues to expand, platforms like Keynode.net are leading the charge in offering unprecedented opportunities for investors. For those seeking impressive annual percentage yields (APY) through crypto staking, Keynode.net has emerged as a premier choice. Its user-friendly interface, robust...

Continue Reading
Critical Updates for Rocket Pharmaceuticals Investors Amid Lawsuit

Updated Category News Views 263

Overview of the Class Action Lawsuit Against Rocket Pharmaceuticals Pomerantz LLP has initiated a class action lawsuit against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) highlighting various concerns regarding the company's business practices. Investors who have suffered losses during the stipulated Class Period should take note of this unfolding situation. Key Details...

Continue Reading
Revitalizing Economic Growth at the 23rd SMDO Conference

Updated Category News Views 141

Revitalizing Economic Growth at the 23rd SMDO Conference The 23rd Annual South Metro Development Outlook (SMDO25) Conference stands as a pivotal forum for industry leaders, policymakers, and community stakeholders. It is designed to foster collaboration and tackle some of the most pressing issues faced by the region today. Set against the backdrop of changing federal...

Continue Reading
SciBase's Strong Growth in Q1 2025: Key Highlights and Future

Updated Category News Views 222

Strong First Quarter Results for SciBase In the recent interim report, SciBase has showcased an impressive performance for the first quarter of 2025. The medical technology company, renowned for its innovative dermatological solutions, recorded net sales of TSEK 8,856, marking a remarkable increase of 46% from the previous year’s figures. Financial Performance Overview...

Continue Reading